If you run a licensed med spa or weight loss clinic, you have probably asked some version of this question: Can we legally source compounded semaglutide, tirzepatide, or peptides for our patients?

The short answer is yes — but only through the right channel, with the right documentation, and from the right type of pharmacy. Get any one of those wrong and you are not just exposed to regulatory risk; you are potentially putting your patients and your license on the line.

This guide breaks down exactly how the 503A compounding model works for licensed clinics, what the legal requirements are, and what to look for in a compliant supply partner.

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies — the kind that compound medications for individual patients based on a valid prescription from a licensed prescriber.

A 503A pharmacy:

• Compounds medications for specific, identified patients based on a valid patient-specific prescription
• Is licensed and regulated at the state level by the applicable state board of pharmacy
• Must comply with USP 795 and USP 797 standards for non-sterile and sterile compounding, respectively
• Cannot compound in anticipation of prescriptions (with limited exceptions for office use in some states)

This is the model that allows licensed clinics to legally receive compounded products — because the prescription originates with your prescribing provider, is patient-specific, and is filled by a licensed pharmacy.

Here is the practical flow for a licensed med spa or weight loss clinic operating under the 503A model:

Step 1: Your prescriber evaluates the patient. A licensed prescriber on your staff (MD, DO, NP, PA — depending on state scope of practice) conducts an appropriate evaluation and determines that a compounded medication is clinically appropriate for that specific patient.

Step 2: A valid prescription is issued. The prescriber writes a patient-specific prescription for the compounded product. This is not a standing order or a blanket authorization — it is a prescription tied to a specific patient encounter.

Step 3: The prescription is sent to a licensed 503A pharmacy. Your clinic transmits the prescription to a licensed 503A compounding pharmacy that is authorized to ship to your state.

Step 4: The pharmacy compounds and ships. The pharmacy compounds the medication to USP standards and ships it directly to your clinic (or in some cases, directly to the patient, depending on state rules).

Step 5: Your clinic dispenses under the prescriber's supervision. The compounded product is dispensed to the patient under the supervision of the prescribing provider.

Every step in this chain has a compliance requirement. Missing any one of them — no valid prescription, unlicensed pharmacy, improper dispensing — creates legal exposure.

Not every compounding pharmacy that markets to clinics is operating within the legal framework. Here is what to verify before you place a single order:

The pharmacy must hold an active pharmacy license in the state where it is compounding and must be authorized to ship to your state. Many states require out-of-state pharmacies to hold a non-resident pharmacy license before shipping into the state. Ask for proof of licensure — a compliant pharmacy will provide it without hesitation.

For sterile compounded products (injectables like semaglutide, tirzepatide, and most peptides), the pharmacy must comply with USP 797 standards for sterile compounding. This includes clean room requirements, beyond-use date (BUD) calculations, and environmental monitoring. Ask for their most recent USP 797 compliance documentation or inspection report.

A compliant 503A pharmacy will require a valid patient-specific prescription for every order. If a pharmacy is offering to ship compounded injectables without a prescription, or is offering "office use" quantities without a clear legal basis in your state, that is a red flag.

Compounded GLP-1s and most peptides are temperature-sensitive. A compliant supply partner ships with validated cold-chain packaging — typically overnight with insulated containers and temperature monitors. Ask about their shipping validation data.

Every batch of compounded product should come with a COA from an independent third-party lab confirming potency, sterility, and the absence of contaminants. This is not optional — it is a basic quality standard.

Even well-intentioned clinic owners make sourcing mistakes that create regulatory exposure. The most common ones:

Sourcing from non-licensed suppliers. Some vendors market "research use only" (RUO) peptides or compounded products without a pharmacy license. These are not legal sources for patient administration, regardless of how they are marketed.

Skipping the per-patient prescription. Some clinics try to streamline operations by ordering in bulk without individual prescriptions. Under the 503A model, this is not compliant. Every patient needs their own prescription.

Not verifying state-specific rules. Compounding regulations vary significantly by state. What is permissible in Texas may not be permissible in California. Your supply partner should be able to confirm compliance with your specific state's rules.

Ignoring BUD dates. Beyond-use dates on compounded products are not the same as expiration dates on manufactured drugs. They are calculated based on the compounding conditions and USP standards. Make sure your team understands BUD requirements and is storing and dispensing products accordingly.

You may have also heard about 503B outsourcing facilities. These are a different category — they compound larger batches and can sell to clinics without patient-specific prescriptions, but only for products on the FDA's approved drug shortage list or under specific conditions.

As of 2026, the FDA has removed semaglutide and tirzepatide from the shortage list, which significantly limits what 503B facilities can legally compound and sell. The 503A model — patient-specific prescriptions through a licensed pharmacy — remains the primary compliant pathway for most clinics sourcing these products.

Understanding this distinction is not just academic. It determines which supply partners you can legally work with and under what conditions.

Before you onboard any compounding pharmacy as a supply partner, ask these questions:

1. Are you licensed in my state (or do you hold a non-resident pharmacy license to ship here)?
2. Do you comply with USP 797 for sterile compounding? Can you provide documentation?
3. Do you require a patient-specific prescription for every order?
4. What is your cold-chain shipping protocol? Do you use validated packaging?
5. Do you provide a COA from an independent lab for each batch?
6. What is your process if a shipment is compromised in transit?
7. How do you handle state-specific regulatory requirements?

A compliant partner will answer all of these questions clearly and provide documentation. If you get vague answers or pushback, that is a signal to look elsewhere.

MedClinic Partners operates as a B2B supply portal connecting licensed clinics with a licensed 503A compounding pharmacy. The model is built around the per-patient prescription requirement — every order through the portal is tied to a valid patient-specific prescription from your clinic's prescribing provider.

The portal is NPI-verified, meaning your clinic's credentials are confirmed before your first order. Products are shipped cold-chain overnight. And the pharmacy behind the portal operates to USP 795/797 standards with independent COA documentation on every batch.

If your clinic is evaluating 503A supply options, the portal is designed to make compliant sourcing straightforward — without the compliance guesswork.

See the full 503A Clinic Supply Program and apply to the portal.

Licensed med spas and weight loss clinics can legally source compounded GLP-1s, peptides, and other compounded products — but only through a licensed 503A pharmacy, with valid patient-specific prescriptions, and in compliance with both federal and state requirements.

The compliance framework is not complicated, but it requires attention to detail at every step: verifying your pharmacy's licensure, maintaining proper prescription documentation, understanding BUD requirements, and staying current on state-specific rules.

The clinics that get this right are the ones that build durable, defensible programs. The ones that cut corners are the ones that end up in front of a state medical board or receiving an FDA warning letter.

Choose your supply partner carefully. Verify everything. And when in doubt, ask for documentation.